200 related articles for article (PubMed ID: 34086776)
1. Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine viral strains in an in vitro model of human blood-brain barrier.
Khou C; Díaz-Salinas MA; da Costa A; Préhaud C; Jeannin P; Afonso PV; Vignuzzi M; Lafon M; Pardigon N
PLoS One; 2021; 16(6):e0252595. PubMed ID: 34086776
[TBL] [Abstract][Full Text] [Related]
2. Japanese encephalitis virus NS1 and NS1' protein disrupts the blood-brain barrier through macrophage migration inhibitory factor-mediated autophagy.
Zhang L; Nan X; Zhou D; Wang X; Zhu S; Li Q; Jia F; Zhu B; Si Y; Cao S; Ye J
J Virol; 2024 May; 98(5):e0011624. PubMed ID: 38591880
[TBL] [Abstract][Full Text] [Related]
3. Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.
Li F; Wang Y; Yu L; Cao S; Wang K; Yuan J; Wang C; Wang K; Cui M; Fu ZF
J Virol; 2015 May; 89(10):5602-14. PubMed ID: 25762733
[TBL] [Abstract][Full Text] [Related]
4. A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: impact of the structural protein region on virulence.
de Wispelaere M; Frenkiel MP; Desprès P
J Virol; 2015 Jun; 89(11):5862-75. PubMed ID: 25787283
[TBL] [Abstract][Full Text] [Related]
5. Brain microvascular endothelial-astrocyte cell responses following Japanese encephalitis virus infection in an in vitro human blood-brain barrier model.
Patabendige A; Michael BD; Craig AG; Solomon T
Mol Cell Neurosci; 2018 Jun; 89():60-70. PubMed ID: 29635016
[TBL] [Abstract][Full Text] [Related]
6. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection.
Wang J; Li X; Gu J; Fan Y; Zhao P; Cao R; Chen P
Infect Genet Evol; 2015 Dec; 36():116-125. PubMed ID: 26384477
[TBL] [Abstract][Full Text] [Related]
7. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
Gromowski GD; Firestone CY; Whitehead SS
J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
[TBL] [Abstract][Full Text] [Related]
8. Axl Deficiency Promotes the Neuroinvasion of Japanese Encephalitis Virus by Enhancing IL-1α Production from Pyroptotic Macrophages.
Wang ZY; Zhen ZD; Fan DY; Qin CF; Han DS; Zhou HN; Wang PG; An J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32611752
[TBL] [Abstract][Full Text] [Related]
9. Infection of pericytes in vitro by Japanese encephalitis virus disrupts the integrity of the endothelial barrier.
Chen CJ; Ou YC; Li JR; Chang CY; Pan HC; Lai CY; Liao SL; Raung SL; Chang CJ
J Virol; 2014 Jan; 88(2):1150-61. PubMed ID: 24198423
[TBL] [Abstract][Full Text] [Related]
10. Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.
Yang J; Yang H; Li Z; Wang W; Lin H; Liu L; Ni Q; Liu X; Zeng X; Wu Y; Li Y
Viruses; 2017 Jan; 9(1):. PubMed ID: 28117725
[TBL] [Abstract][Full Text] [Related]
11. Japanese encephalitis virus disrupts blood-brain barrier and modulates apoptosis proteins in THBMEC cells.
Al-Obaidi MMJ; Bahadoran A; Har LS; Mui WS; Rajarajeswaran J; Zandi K; Manikam R; Sekaran SD
Virus Res; 2017 Apr; 233():17-28. PubMed ID: 28279803
[TBL] [Abstract][Full Text] [Related]
12. [Construction of infectious Japanese encephalitis virus clone based on the cDNA template of the attenuated live vaccine production strain SA14-14-2].
Zeng M; Jia LL; Yu YX; Dong GM; Liu WX; Wang ZW; Li DF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):9-11. PubMed ID: 16201461
[TBL] [Abstract][Full Text] [Related]
13. Mice with different susceptibility to Japanese encephalitis virus infection show selective neutralizing antibody response and myeloid cell infectivity.
Wang K; Deubel V
PLoS One; 2011; 6(9):e24744. PubMed ID: 21949747
[TBL] [Abstract][Full Text] [Related]
14. Sequence duplication in 3' UTR modulates virus replication and virulence of Japanese encephalitis virus.
Zhang QY; Liu SQ; Li XD; Li JQ; Zhang YN; Deng CL; Zhang HL; Li XF; Fang CX; Yang FX; Zhang B; Xu Y; Ye HQ
Emerg Microbes Infect; 2022 Dec; 11(1):123-135. PubMed ID: 34877923
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo.
Yun SI; Song BH; Polejaeva IA; Davies CJ; White KL; Lee YM
J Gen Virol; 2016 Oct; 97(10):2575-2591. PubMed ID: 27498826
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of an animal model of Japanese encephalitis virus infection in adolescent C57BL/6 mouse.
Tripathi A; Banerjee A; Vrati S
Dis Model Mech; 2021 Oct; 14(10):. PubMed ID: 34447981
[TBL] [Abstract][Full Text] [Related]
17. Molecular phylogenetic and positive selection analysis of Japanese encephalitis virus strains isolated from pigs in China.
Liu WJ; Zhu M; Pei JJ; Dong XY; Liu W; Zhao MQ; Wang JY; Gou HC; Luo YW; Chen JD
Virus Res; 2013 Dec; 178(2):547-52. PubMed ID: 24045128
[TBL] [Abstract][Full Text] [Related]
18. Japanese encephalitis virus neuropenetrance is driven by mast cell chymase.
Hsieh JT; Rathore APS; Soundarajan G; St John AL
Nat Commun; 2019 Feb; 10(1):706. PubMed ID: 30742008
[TBL] [Abstract][Full Text] [Related]
19. Ezrin is essential for the entry of Japanese encephalitis virus into the human brain microvascular endothelial cells.
Liu YG; Chen Y; Wang X; Zhao P; Zhu Y; Qi Z
Emerg Microbes Infect; 2020 Dec; 9(1):1330-1341. PubMed ID: 32538298
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
